Publication | Open Access

PIKfyve, a Class III PI Kinase, Is the Target of the Small Molecular IL-12/IL-23 Inhibitor Apilimod and a Player in Toll-like Receptor Signaling

InflammationCytokineSignal TransductionSignaling PathwayReceptor Tyrosine KinaseImmunologyToll-like ReceptorCell DeathMedicineCell BiologyCell Signaling